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Abstract
Introduction: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is characterized by features other
than increased pulmonary vascular permeability. Pulmonary vascular permeability combined with increased
extravascular lung water content has been considered a quantitative diagnostic criterion of ALI/ARDS. This
prospective, multi-institutional, observational study aimed to clarify the clinical pathophysiological features of
ALI/ARDS and establish its quantitative diagnostic criteria.
Methods: The extravascular lung water index (EVLWI) and the pulmonary vascular permeability index (PVPI) were
measured using the transpulmonary thermodilution method in 266 patients with PaO2/FiO2 ratio ≤ 300 mmHg and
bilateral infiltration on chest radiography, in 23 ICUs of academic tertiary referral hospitals. Pulmonary edema was
defined as EVLWI ≥ 10 ml/kg. Three experts retrospectively determined the pathophysiological features of
respiratory insufficiency by considering the patients’ history, clinical presentation, chest computed tomography and
radiography, echocardiography, EVLWI and brain natriuretic peptide level, and the time course of all preceding
findings under systemic and respiratory therapy.
Results: Patients were divided into the following three categories on the basis of the pathophysiological
diagnostic differentiation of respiratory insufficiency: ALI/ARDS, cardiogenic edema, and pleural effusion with
atelectasis, which were noted in 207 patients, 26 patients, and 33 patients, respectively. EVLWI was greater in ALI/
ARDS and cardiogenic edema patients than in patients with pleural effusion with atelectasis (18.5 ± 6.8, 14.4 ± 4.0,
and 8.3 ± 2.1, respectively; P < 0.01). PVPI was higher in ALI/ARDS patients than in cardiogenic edema or pleural
effusion with atelectasis patients (3.2 ± 1.4, 2.0 ± 0.8, and 1.6 ± 0.5; P < 0.01). In ALI/ARDS patients, EVLWI increased
with increasing pulmonary vascular permeability (r = 0.729, P < 0.01) and was weakly correlated with intrathoracic
blood volume (r = 0.236, P < 0.01). EVLWI was weakly correlated with the PaO2/FiO2 ratio in the ALI/ARDS and
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cardiogenic edema patients. A PVPI value of 2.6 to 2.85 provided a definitive diagnosis of ALI/ARDS (specificity, 0.90
to 0.95), and a value < 1.7 ruled out an ALI/ARDS diagnosis (specificity, 0.95).
Conclusion: PVPI may be a useful quantitative diagnostic tool for ARDS in patients with hypoxemic respiratory
failure and radiographic infiltrates.
Trial registration: UMIN-CTR ID UMIN000003627
Introduction
Pulmonary edema is characterized by the abnormal accu-
mulation of fluid in the extravascular space of the lungs
and is a common finding in critically ill patients [1]. This
pathological condition may develop due to an increase in
the pulmonary capillary permeability (acute lung injury
(ALI), acute respiratory distress syndrome (ARDS)), an
increase in the pulmonary capillary hydrostatic pressure
(hydrostatic or cardiogenic pulmonary edema), or both
[2]. Pulmonary edema can be detected by clinical evalua-
tion of factors such as patients’ history, physical findings,
and routine laboratory examinations, and is confirmed by
the presence of bilateral pulmonary infiltration on chest
radiography [2,3]. However, interpretation of these factors
is often limited by a certain degree of subjectivity that
might cause inter-observer variation even among experts,
particularly in critically ill patients [4-6]. Moreover, inten-
sive care physicians may find it difficult to determine the
cause of the extravascular lung water (EVLW) increase [7].
In 1994 the American Thoracic Society and the Eur-
opean Society of Intensive Care Medicine co-published
the proceedings of a consensus conference on ARDS, and
defined ALI and ARDS as an American-European Consen-
sus Conference (AECC) definition [8,9]. Although many
clinical trials performed after the publication of the pro-
ceedings used the AECC definition, this definition has
been suggested to have various issues, including a lack of
explicit criteria for defining what is acute, the sensitivity of
the PaO2/FiO2 (P/F) ratio to different ventilator settings,
poor reliability of the chest radiograph criterion, and diffi-
culties distinguishing hydrostatic edema [10-14]. These
criteria are also not sensitive predictors of disease severity
and outcomes [4,5,15-17] because: the P/F ratio varies
considerably across different FiO2 levels, particularly when
FiO2 < 0.5, PaO2 > 100 mmHg, or when the shunt fraction
is low; many patients who initially fulfill the ARDS criteria
might improve the P/F ratio > 200 mmHg after application
of positive end-expiratory pressure for a short time or the
use of higher FiO2; and hypoxemia in ARDS may also be
related to atelectasis or a low cardiac output [14]. Based
on these limitations, a novel definition has been proposed
that takes into account the clinical and physiologic charac-
teristics of ALI/ARDS [18]. The Berlin definition for
ARDS was published recently and was demonstrated to
have better predictive validity for mortality than the AECC
definition [10]. Although ARDS has been described as a
type of acute, diffuse inflammatory lung injury leading to
increased pulmonary vascular permeability, increased lung
weight, and loss of aerated lung tissue, as the panel agreed
in their conceptual model, none of the suggested criteria
evaluates the increase in pulmonary microvascular perme-
ability, a hallmark of ARDS [10]. Not only the AECC defi-
nition but also the Berlin definition may include an
extensive range of respiratory insufficiencies without an
increase in pulmonary microvascular permeability.
Previous studies have reported on methods of quanti-
fying pulmonary edema [19,20]. The double-indicator
thermodilution technique allows the measurement of
EVLW, and excellent correlation between in vivo and
postmortem gravimetric EVLW values was obtained in
both animal and human studies using this method
[21,22]. However, this method is cumbersome and tech-
nically challenging for routine clinical application. The
single-indicator technique is therefore used in clinical
settings; this method is as sensitive as the double-indica-
tor technique [23,24]. We previously validated the
accuracy of EVLW measurements obtained using the
single-indicator technique in the postmortem lung sam-
ples and defined the statistically normal EVLW values in
a human autopsy study [25]. The close relationship
between EVLW and outcome has been also demon-
strated [26].
The transpulmonary thermodilution technique pro-
vides an estimation of both EVLW and the pulmonary
blood volume, and the ratio of these two parameters -
the pulmonary vascular permeability index (PVPI) - has
been shown to reflect the pulmonary microvascular per-
meability [7,27].
Increased pulmonary vascular permeability is the cru-
cial pathophysiological feature of ALI/ARDS and has
been considered a quantitative diagnostic criterion for
ALI/ARDS [28]. PVPI has been evaluated to enable one
to differentiate ALI/ARDS from hydrostatic edema [7].
PVPI was shown to be useful for determining the
mechanism of pulmonary edema in ALI/ARDS, and
PVPI ≥ 3 allowed the diagnosis of ALI/ARDS with a
sensitivity of 85% and a specificity of 100%. However,
that study was a single-center retrospective review of
only 48 patients (ALI/ARDS, 36 patients; hydrostatic
edema, 12 patients).
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The aims of this study were to clarify the clinical
pathophysiological features of ALI/ARDS, and to estab-
lish the quantitative differential criteria of ALI/ARDS on
the basis of PVPI assessed using the transpulmonary
single thermodilution technique.
Materials and methods
This prospective, observational, multi-institutional study
was approved by the ethics committee of each of the 23
institutions, and written informed consent was provided
by all patients’ next of kin. The study was registered
with the University Hospital Medical Information Net-
work Clinical Trials Registry: UMIN-CTR ID
UMIN000003627.
Patients
Between March 2009 and August 2011, 301 patients
from 23 critical care centers at tertiary care hospitals
were enrolled in this study. In all of 23 participating
institutions, the single transpulmonary thermodilution
technique is one of the standard monitoring methods
for circulatory and respiratory management of critically
ill patients. The median (interquartile range) number of
included patients per each institution was 10 (6 to 18).
The inclusion criteria were aged older than 15 years,
requiring mechanical ventilation (expected over 48 hours)
for acute respiratory failure with a P/F ratio ≤ 300 mmHg
and bilateral infiltration on chest radiography and transpul-
monary thermodilution technique monitoring of circula-
tory/respiratory status as per the attending physician’s
discretion. Exclusion criteria were as follows: over 5 days
from the onset of acute respiratory failure with a P/F ratio
≤ 300; chronic respiratory insufficiency (chronic obstruc-
tive pulmonary disease, and so forth); history of pulmonary
resection/pneumonectomy, pulmonary thromboembolism,
and severe peripheral arterial disease; cardiogenic shock
with a cardiac index < 1.5 l/minute/m2; acute phase of
trauma with lung contusion and burns; other causes ren-
dering patients unsuitable for evaluation with the transpul-
monary thermodilution technique, including patients with
moderate to severe valvopathy; and the attending physician
identifying patients as inappropriate for inclusion.
Of the 301 enrolled patients, 266 were included in this
analysis. Reasons for the exclusion of 35 patients are
shown in Figure 1.
In this study, the diagnosis of pulmonary edema was
established on the basis of: the presence of bilateral
infiltrates on chest radiography; P/F ratio ≤ 300 mmHg;
and an increase in the EVLW indexed to the predicted
body weight (extravascular lung water index (EVLWI))
≥ 10 ml/kg. Although there is no definitive quantitative
criterion of EVLWI for pulmonary edema, we recently
reported that the normal EVLWI value is approximately
7.4 ± 3.3 ml/kg for humans [25]. EVLWI ≥ 10 ml/kg
was used for definition of pulmonary edema in the pre-
viously reported study [1,29].
Measurement of EVLWI and PVPI using the
transpulmonary thermodilution method
A 4-Fr or 5-Fr femoral arterial or 4-Fr brachial arterial
thermistor-tipped catheter (PV2014L16N, PV2015L20N,




㻌 26 cardiogenic edema
33 pleural effusion 㻌 㻌 㻌
with atelectasis
㻌 35 excluded
㻌 䖃14, respiratory insufficiency secondary to sepsis without elevation of EVLWi
       to >10 mL/kg  due to hypovolemia
㻌 䖃8, unclassified by expert decision
㻌 䖃5, atelectasis and consolidation due to pneumonia
㻌 䖃3, acute phase of trauma with lung contusion/burn
㻌 䖃2, nonacute onset
㻌 䖃1, near drowning
㻌 䖃1, combined with COPD
㻌 䖃1, after lung resection
Figure 1 Patient enrollment, exclusion, and classification. ALI, acute lung injury; ARDS, acute respiratory distress syndrome; COPD, chronic
obstructive pulmonary disorder; EVLWI, extravascular lung water index.
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Germany) was inserted in all patients by the attending
physicians’ discretion and connected to the PiCCO® plus
or PiCCO® 2 monitor (Pulsion Medical Systems). The
monitor uses a single-thermal indicator technique to cal-
culate the cardiac output (CO), global end-diastolic
volume (GEDV), EVLW, and other volumetric parameters.
A 15 ml bolus of 5% glucose at 5°C was injected through a
central venous catheter, and the CO calculated using the
Stewart-Hamilton method. A 15 ml bolus dose was
selected as previously described [25] and the precision of
measurements has been demonstrated [30,31]. The central
venous catheters were accessed from the jugular or subcla-
vian route in all patients. Concurrently, the mean transit
time and exponential downslope time of the transpulmon-
ary thermodilution curve were calculated. The product of
CO and mean transit time represents the intrathoracic
thermal volume [23]. The product of CO and exponential
downslope time represents the pulmonary thermal volume
[32]. GEDV is calculated as the difference between the
intrathoracic thermal volume and the pulmonary thermal
volume, and represents the combined end-diastolic
volumes of the four cardiac chambers. The intrathoracic
blood volume (ITBV) is calculated as the linear relation-
ship with the GEDV [23]:
ITBV = 1.25 × GEDV − 28.4
EVLW is the difference between the intrathoracic
thermal volume and ITBV [23,32]. The detailed princi-
ples and calculations involved in deriving EVLW using
the thermodilution technique are discussed elsewhere
[7,33]. PVPI is calculated as the ratio of EVLW and pul-
monary blood volume [7]. ITBV and GEDV are indexed
to the body surface area.
The median EVLW value was obtained after three bolus
injections of 15 ml each [31]. The absolute EVLW value
was indexed to predicted body weight, calculated as 50 +
0.91 (height (cm) - 152.4) for males and 45.5 + 0.91 (height
(cm) - 152.5) for females [34]. For indexing EVLW, the
predicted body weight instead of the actual body weight
was used because: lung volumes are dependent on gender
and height, not on weight [35]; measurement of EVLW
indexed to the actual body weight can be underestimated
in obese patients [36,37]; and the EVLWI has been shown
to be a better prognostic indicator than EVLW indexed to
the actual body weight [38-40]. The results were analyzed
using PiCCO-VoLEF Data Acquisition for Win32 Version
6.0 for PiCCO® plus or Version 2.0.0.13 for PiCCO®
2 (Pulsion Medical Systems).
Assessment of circulatory/respiratory status, other
parameters, and clinical course
At the time of enrollment (day 0), the clinical conditions,
cause of respiratory insufficiency, Acute Physiology and
Chronic Health Evaluation II score, Sequential Organ
Failure Assessment score, and Lung Injury Scale score
were assessed [41,42]. Echocardiography was performed to
measure the left ventricular ejection fraction, left ventricu-
lar end-diastolic dimension, interventricular septum thick-
ness, E/A ratio, left atrial dimension, inferior vena cava
diameter and its respiratory variation, presence of hypo/
akinesis, valvular abnormality, left ventricular systolic/dia-
stolic function, and the thermodilution hemodynamic
assessment validity. Chest computed tomography was also
conducted on the day of enrollment. B-type natriuretic
peptide (BNP) or N-terminal pro-BNP was measured on
the day of enrollment and daily thereafter.
From the day of enrollment to day 2, the circulatory/
respiratory status and other parameters except for rou-
tine clinical workup were assessed; the clinical course,
including respirator settings, Lung Injury Scale score
[43], Sequential Organ Failure Assessment score, antith-
rombin activity level, serum procalcitonin level, daily
fluid intake/output and balance, and therapeutic inter-
ventions (surgery, antibiotics, steroids, diuretics, renal
replacement therapy, and so forth) were recorded daily.
All patients were followed for 28 days after enrollment
and assessed for 28-day all-cause mortality.
Determination of pathophysiological diagnostic
differential of respiratory insufficiency
At least three experts (intensive care, respiratology, and
cardiology) retrospectively determined the pathophysiolo-
gical mechanism of respiratory insufficiency: ALI/ARDS,
increased pulmonary vascular permeability without or
with increased pulmonary vascular hydrostatic pressure;
cardiogenic edema, increased pulmonary capillary hydro-
static pressure without increased vascular permeability;
and pleural effusion with atelectasis, no evidence of lung
edema secondary to increased hydrostatic pressure or vas-
cular permeability, as previously reported [7,44]. For this
purpose, the experts particularly considered the patients’
medical history, clinical presentation and the course, chest
computed tomography and radiography findings, echocar-
diography findings, and serum BNP or N-terminal pro-
BNP and procalcitonin concentrations, and systemic
inflammatory status. The pulmonary capillary wedge pres-
sure was not routinely obtained in this study and any
pressures measured depended on the attending physicians’
discretion and was only obtained for selected patients. The
physicians also considered in particular the time course of
all the preceding findings, including daily fluid intake/out-
put and balance, hemodynamic parameters obtained from
the thermodilution method, the requirement for systemic
management and respiratory therapy, and the clinical
responses to these treatments. In this study, EVLWI
≥ 10 ml/kg was used for definition of pulmonary edema,
and patients with EVLWI ≥ 10 ml/kg were discriminated
between permeability and hydrostatic pulmonary edema.
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The experts who provided the final diagnosis were com-
pletely blinded to the PVPI, but not to hemodynamic para-
meters such as cardiac index, stroke volume index, ITBV
and EVLWI.
Statistical analysis
Data are presented as mean ± standard error or as med-
ian (interquartile range) depending on the distribution
normality of the variables. Spearman’s rank correlation
was used for determining the correlation between two
variables, and Mann-Whitney’s U test was used for
assessing the differences between two groups. For multi-
ple-group comparison, analysis of variance on ranks
with a Tukey honestly significant difference test was
used. Receiver operating characteristic curves were gen-
erated for PVPI and ITBV by varying the discriminating
threshold of each parameter. The area under the recei-
ver operating characteristic curve for each parameter
was calculated and compared using a Hanley-McNeil
test. P < 0.05 was considered significant. All statistical
analyses were performed using SPSS 19.0 for Windows
(SPSS, Chicago, IL, USA).
Results
Patient characteristics
The most frequent condition leading to exclusion of
patients was respiratory insufficiency (P/F ratio ≤ 300
mmHg and slight bilateral infiltration) secondary to sep-
sis suggesting ALI but not accompanied by EVLWI ≥ 10
ml/kg - the predefined value for pulmonary edema, due
to hypovolemia. Consensus on inclusion of such patients
was not obtained from all attending experts.
For this analysis, 266 patients were included and
divided into the following three categories on the basis
of the pathophysiological diagnostic differentiation of
the respiratory insufficiency: ALI/ARDS, cardiogenic
edema (including fluid overload), and pleural effusion
with atelectasis. ALI/ARDS complicated by increased
hydrostatic pressure was judged as ALI/ARDS.
Table 1 presents the patient characteristics at the time of
enrollment. No patient with body mass index ≥ 30 was
included. The incidence of sepsis as a baseline condition
was higher in the ALI/ARDS patients than in cardiogenic
edema and pleural effusion with atelectasis patients. The
period of ventilator-free days within 28 days was signifi-
cantly longer in patients with cardiogenic edema. Mortal-
ity was assessed by 28-day all-cause mortality and there
was no significant difference between the three groups.
On the day of enrollment, ALI/ARDS patients had higher
Acute Physiology and Chronic Health Evaluation II and
Sequential Organ Failure Assessment scores than patients
with cardiogenic edema, and had higher Lung Injury Scale
scores than patients with pleural effusion with atelectasis.
ITBV was highest in the cardiogenic edema patients.
Table 2 shows the underlying condition and mechanism
in patients with ALI/ARDS, with 128 of 207 cases caused
by sepsis. The most frequent site of infection was the
respiratory tract, and in 125 patients the injury was direct.
Comparison of extravascular lung water index and
pulmonary vascular permeability index
The EVLWI on the day of enrollment was significantly
higher in ALI/ARDS patients than in patients with pleural
effusion with atelectasis (18.5 ± 6.8 vs. 8.3 ± 2.1; P < 0.01)
or cardiogenic edema (14.4 ± 4.0; P < 0.01) (Figure 2). The
PVPI on the day of enrollment was higher in the ALI/
ARDS patients than in cardiogenic edema or pleural effu-
sion with atelectasis patients (3.2 ± 1.4, 2.0 ± 0.8, and
1.6 ± 0.5, respectively). Although the EVLWI was higher
in the cardiogenic edema than in pleural effusion with
atelectasis patient (Figure 2), there was no significant dif-
ference in PVPI between those groups (Figure 3).
These differences were also noted when the maximal
values of EVLWI and PVPI recorded during the study
period were compared among the three groups (Figures
2 and 3).
Relationship among EVLWI, PVPI, and intrathoracic blood
volume
For this analysis, cardiogenic edema and pleural effusion
with atelectasis patients were considered non-ALI/ARDS
patients because increased pulmonary vascular perme-
ability is not the pathogenetic mechanism of these con-
ditions and was not elevated compared with that in
ALI/ARDS patients.
In the ALI/ARDS patients, a strong correlation between
EVLWI and PVPI (r = 0.729, P < 0.01) and a weak correla-
tion between EVLWI and ITBV (r = 0.236, P < 0.01) were
noted on the day of enrollment (Figure 4). In the non-ALI/
ARDS patients, moderate correlations between EVLWI
and PVPI (r = 0.464, P < 0.01) and between EVLWI and
ITBV (r = 0.493, P < 0.01) were noted (Figure 5).
Multiple regression analysis was also performed using
EVLWI as the dependent variable with PVPI and ITBV
as the independent variables. The standardized partial
regression coefficients were 0.958 for PVPI and 0.646
for ITBV in ALI/ARDS patients, and were 0.836 and
0.814 in non-ALI/ARDS patients, respectively, suggest-
ing the important contribution of PVPI on the EVLWI
in ALI/ARDS.
Relationship between extravascular lung water index and
PaO2/FiO2 ratio
For this analysis, patients with pleural effusion with
atelectasis were excluded because the increased EVLW
is not the pathogenetic mechanism of this condition,
and EVLWI in these patients was not high as in those
patients with ALI/ARDS and cardiogenic edema.
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The P/F ratio varied widely at all levels of EVLWI in
patients with both ALI/ARDS and cardiogenic edema
(Figure 6). A negative but weak correlation was noted
between EVLWI and the P/F ratio in all patients except
for those with pleural effusion with atelectasis (r =
-0.213, P < 0.01) and ALI/ARDS (r = -0.215, P < 0.01).
No correlation was found between EVLWI and PVPI in
cardiogenic edema patients (r = -0.176, P = 0.39).
Differential diagnosis of ALI/ARDS on the basis of
pulmonary vascular permeability
Receiver operating characteristic curves were generated
using PVPI and ITBV on the day of enrollment to dif-
ferentiate between ALI/ARDS patients and non-ALI/
ARDS patients. The area under the curve for PVPI
(0.886; confidence interval, 0.836 to 0.935) was signifi-
cantly larger than that for ITBV (0.575; confidence
interval, 0.471 to 0.651; P < 0.01) (Figure 7).
The cutoff value for the definitive quantitative diagno-
sis of ALI/ARDS needs to be determined considering
the high specificity despite the decreased level of sensi-
tivity, as discussed in the next section. The cutoff value
of the PVPI to diagnose ALI/ARDS was found to be
between 2.85 (sensitivity, 0.54; specificity, 0.95) and 2.6
(sensitivity, 0.64; specificity, 0.90). The cutoff value of
the PVPI to diagnose non-ALI/ARDS was between 1.7
(sensitivity, 0.50; specificity, 0.95) and 2.0 (sensitivity,
0.70; specificity, 0.90).
Table 1 Patient characteristics
Variable All (n = 266) ALI/ARDS (n = 207) Cardiogenic edema (n = 26) Pleural effusion with atelectasis (n = 33)
Age (years) 67.3 ± 16.2 66.7 ± 16.8 70.0 ± 12.5 69.4 ± 14.3
Male 175 (65.3%) 134 (64.7%) 14 (53.8%) 27 (77.1%)
Height (cm) 159.8 ± 10.0 159.4 ± 10.0 157.8 ± 10.4 163.4 ± 9.3
Body weight (kg) 55.2 ± 10.6 54.8 ± 10.6 52.8 ± 11.1 59.2 ± 9.8
BSA (m2) 1.56 ± 0.20 1.55 ± 0.20 1.52 ± 0.21 1.64 ± 0.18
Body mass index 21.3 ± 1.8 21.3 ± 1.8 20.9 ± 1.9 22.0 ± 1.5
Heart rate (beats/minute) 102 ± 25 103 ± 22 95 ± 26 103 ± 37
MAP (mmHg) 77 ± 18 76 ± 17 80 ± 18 79 ± 20
Vasopressor 180 (70.7%) 148 (71.5%)* 10 (38.5%)## 22 (66.7%)
Sepsis 144 (54.1%) 128 (61.8%)*,# 4 (15.4%) 12 (36.3%)
APACHE II score (points) 22.7 ± 8.0 23.4 ± 8.1** 19.7 ± 6.5 20.7 ± 7.7
SOFA score (points) 10.4 ± 3.7 10.7 ± 3.6* 8.1 ± 3.9 10.3 ± 3.5
Respiratory 1.2 ± 1.2 1.2 ± 1.3 0.77 ± 1.1 1.5 ± 0.9
Coagulation 0.9 ± 1.2 0.9 ± 1.1 1.0 ± 1.5 0.9 ± 1.1
Liver 2.3 ± 1.7 2.5 ± 1.6* 1.3 ± 1.6## 2.4 ± 1.7
Cardiovascular 0.7 ± 1.0 0.7 ± 1.0 0.4 ± 0.8 0.8 ± 1.0
Central nervous system 3.0 ± 0.8 3.1 ± 0.8* 2.8 ± 0.7 2.7 ± 0.7
Renal 2.3 ± 1.4 2.4 ± 1.4 2.0 ± 1.3 2.0 ± 1.5
PEEP (cmH2O) 8.6 ± 4.5 8.7 ± 4.7 7.9 ± 4.2 8.9 ± 3.5
Plateau pressure (cmH2O) 22.1 ± 5.7 22.3 ± 5.6 20.6 ± 6.9 21.5 ± 5.2
PaO2/FIO2 ratio (mmHg) 155.3 ± 70.7 150.5 ± 70.9 166.7 ± 69.8 176.2 ± 67.5
Lung Injury Score (points) 2.3 ± 0.6 2.3 ± 0.6# 2.3 ± 0.6 1.8 ± 0.7
Ejection fraction (%) 55.1 ± 13.1* 56.4 ± 12.1* 46.8 ± 13.0 55.0 ± 17.0
Stroke volume variation (%) 15 ± 7 16 ± 7* 11 ± 6## 16 ± 7
Cardiac index (l/m2/minute) 3.4 ± 1.2 3.5 ± 1.3 3.0 ± 1.0 3.4 ± 1.2
ITBV (ml/m2) 1040 ± 303 1021 ± 257* 1312 ± 527## 948 ± 215
EVLWI (ml/kg) 16.8 ± 7.1 18.5 ± 6.8*,# 14.4 ± 4.0# 8.3 ± 2.1
PVPI 2.9 ± 1.4 3.2 ± 1.4*,# 2.0 ± 0.8 1.6 ± 0.5
Maximal EVLWI (ml/kg) 19.2 ± 8.5 21.2 ± 8.1*,# 16.4 ± 7.5# 9.4 ± 2.1
Maximal PVPI 3.4 ± 1.6 3.7 ± 1.6*,# 2.2 ± 1.2 1.9 ± 0.6
VFD within 28 days (days) 11.3 ± 10.3 9.8 ± 9.9* 20.3 ± 8.0## 13.1 ± 10.7
28-day mortality 99 (37.2%) 84 (40.6%) 7 (26.9%) (24.2%)
Data presented as mean ± standard deviation or n (%). Data on the day of enrollment were presented, except for maximal extravascular lung water index
(EVLWI), and maximal pulmonary vascular permeability index (PVPI) during the 3-day study period. ALI/ARDS, acute lung injury/acute respiratory distress
syndrome; APACHE, Acute Physiology and Chronic Health Evaluation; BSA, body surface area; ITBV, intrathoracic blood volume index; MAP, mean arterial
pressure; PEEP, positive end-expiratory pressure; SOFA, Sequential Organ Failure Assessment; VFD, ventilator-free days. *P < 0.01 vs. cardiogenic edema, **P <
0.05 vs. cardiogenic edema, #P < 0.01 vs. pleural effusion with atelectasis, ##P < 0.05 vs. pleural effusion with atelectasis.
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Discussion
In this prospective multi-institutional observational study,
EVLW and pulmonary vascular permeability were assessed
by transpulmonary thermodilution in patients requiring
mechanical ventilation with P/F ratio ≤ 300 mmHg and
bilateral pulmonary infiltration on chest X-ray scan. The
results showed that EVLW was greater in patients with
ALI/ARDS and cardiogenic edema than in those with
pleural effusion with atelectasis; that pulmonary vascular
permeability was increased in patients with ALI/ARDS
compared with cardiogenic edema and pleural effusion
with atelectasis patients; and that EVLW, the crucial
pathogenetic factor of pulmonary edema, was weakly cor-
related with the P/F ratio in patients with ALI/ARDS and
cardiogenic edema.
ARDS is associated with a high incidence of morbidity
and mortality despite the development of improved
management techniques over the past two decades [45].
Difficulties in selecting appropriate patient populations
that would benefit from specific treatments occur largely
because of the lack of homogeneity in the disease defini-
tion. The AECC criteria, which have been exclusively
used as the inclusion criteria in clinical trials for ALI/
ARDS, were designed to identify patients with ALI/
ARDS [9]. These criteria are inclusive, so that the popu-
lation selected on the basis of these criteria can be very
heterogeneous in disease severity and clinical outcomes.
This heterogeneity might be the reason why most clini-
cal trials in ARDS have failed to achieve improved mor-
tality. There is no validated biomarker that allows early
recognition of increased lung vascular permeability, the
hallmark of ALI/ARDS pathogenesis. Although the Ber-
lin definition is expected to have sufficient specificity
and acceptable sensitivity, an accurate definition can
also help clinicians identify patients who may benefit
from precise ventilatory strategies, diagnostic proce-
dures, or drug therapies.
Although pulmonary capillary hydrostatic pressure
elevation and pulmonary vascular permeability increase
are known to induce pulmonary edema, discrimination of
these pathogeneses is important because of the difference
in treatments. At present, the differential diagnosis is
made on the basis of the assessment of left atrial pressure,
which is assumed to be normal in ALI/ARDS [46]. How-
ever this hemodynamic definition of ALI/ARDS is contro-
versial, as suggested previously [47]. The pulmonary artery
occlusion pressure might not reflect the hydrostatic pres-
sure in the pulmonary micro-vessels [48,49] and cannot be
accurately measured [50,51]. Moreover, left ventricular
preload might be elevated in ALI/ARDS patients, espe-
cially in those who have already received volume resuscita-
tion and/or pre-existing or sepsis-related cardiac
dysfunction, as described in the Berlin definition [10]. The
pulmonary artery occlusion pressure was recently found to
be elevated in 30% of ARDS patients [52]. The definition
of ALI/ARDS should thus include the functional features
of the pathophysiology of this syndrome; that is, increased
pulmonary microvascular permeability [46]. The PVPI has
been suggested to be an important parameter in ALI/
ARDS pathogenesis [53].
EVLWI in ALI/ARDS, cardiogenic edema, and pleural
effusion with atelectasis
A close agreement between thermodilution EVLW
values and gravimetric lung water measurements, which
are thought to be the gold standard for the quantitative
evaluation of EVLW, has been shown in animal models
with lung injury [27,54,55] and in a human autopsy
study [25].
In this study, EVLWI ≥ 10 ml/kg was defined as pul-
monary edema. Although no definitive quantitative cri-
teria of EVLWI for pulmonary edema were established,
we recently reported that the normal EVLWI value is
approximately 7.4 ± 3.3 ml/kg from a human autopsy
study and this value can distinguish between healthy
and pathological lungs [24]. Because EVLWI ≥ 10 ml/kg
has been shown to predict progression to acute lung
injury, this value was used for defining pulmonary
edema in this study [1,29]. Only three patients had
EVLWI < 10 ml/kg from the 155 ARDS patients, based
on the AECC definition.
Regarding the effect of pleural effusion on EVLW
measurements, Blomqvist and colleagues showed that
the pleural fluid level did not affect the reliability of the
Table 2 Underlying conditions and mechanism for














Central nervous system 4
Severe acute pancreatitis 3
Vascular diseases 2
Others 29
Direct or indirect lung injury
Direct injury 125
Indirect injury 82
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double-indicator dilution technique for measuring
EVLW in dogs [56]. This relationship has been also
demonstrated using the single indicator thermodilution
method in critically ill patients in a previous study [57].
We showed a very close correlation between premortem
single-indicator thermodilution measurement of EVLW
and postmortem lung weight, regardless of the degree of
pleural effusion [25]. In this study, the EVLWI of
patients with pleural effusion with atelectasis was less
than the defined value of pulmonary edema, despite the
fact that patients had P/F ratio ≤ 300 mmHg and bilat-
eral infiltration. This suggests that the EVLWI value
might not be significantly influenced by pleural effusion
with or without massive atelectasis. If patients have
EVLWI < 10 ml/kg but P/F ratio ≤ 300 mmHg and
bilateral infiltration, thoracic ultrasound for the evalua-
tion of pleural effusion should be performed.
The EVLWI value was different between ALI/ARDS
and cardiogenic edema in this study. Hydrostatic pressure
elevation occurred without a significant increase in vascu-
lar permeability in patients with cardiogenic edema,
whereas both increased vascular permeability and ele-
vated hydrostatic pressure contributed to the develop-




䠆: p < 0.01 vs. pleural effusion with atelectasis















Figure 2 Comparison of extravascular lung water indexed to predicted body weight. Comparison of extravascular lung water indexed to
predicted body weight of patients with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), cardiogenic edema, and pleural
effusion with atelectasis on the day of enrollment and the maximal value during the study period. (A) Extravascular lung water indexed to
predicted body weight (EVLWI) on the day of enrollment was significantly higher in ALI/ARDS patients than in pleural effusion with atelectasis
patients and cardiogenic edema patients. EVLWI was also higher in cardiogenic edema patients than in pleural effusion with atelectasis patients.
(B) Differences were found when the maximal EVLWI value was compared between day 0 and day 2. Data presented as median (interquartile
range). *P < 0.01 vs. pleural effusion with atelectasis. **P < 0.01 vs. cardiogenic edema. EVLWI-0, extravascular lung water index on day of
enrollment; maxEVLWI, maximal value of extravascular lung water index from days 0 to 2.
Kushimoto et al. Critical Care 2012, 16:R232
http://ccforum.com/content/16/6/R232
Page 8 of 15
suggested, left ventricular preload can be elevated in ALI/
ARDS, especially in patients who already have volume
resuscitation and/or have pre-existing or sepsis-related
cardiac dysfunction [10,52]. In this regard, more than
15% of the ALI/ARDS patients included in this study had
a combined mechanism of an elevated left ventricular
preload and vascular permeability; this may have contrib-
uted to the difference in EVLWI between the two groups.
One should also consider that the heterogeneity of the
patients’ condition may affect the value of the EVLWI, as
shown in a recent meta-analysis where the EVLWI in
septic patients was higher than in surgical patients
(11.0 ml/kg vs. 7.2 ml/kg) [58].
Determination of the cutoff value for ALI/ARDS diagnosis
Although EVLW has been extensively evaluated as not
only a predictor but also a diagnostic and prognostic
parameter for ALI/ARDS [59], this value provides only
the degree of accumulated EVLW and not the underly-
ing pathophysiological mechanism.
Increased pulmonary vascular permeability can be esti-
mated by the PVPI [53]. A recent retrospective study
showed EVLWI values of 22 ± 9 and 16 ± 4 in patients
with ARDS and hydrostatic pulmonary edema, respectively
[7]. On the contrary, in our study, these values were 18.5 ±
6.8 and 8.3 ± 2.1, respectively. These differences might
have influenced the PVPI values obtained in both studies
䠆 
䠆: p < 0.01 vs. pleural effusion with atelectasis




Figure 3 Comparison of pulmonary vascular permeability index. Comparison of pulmonary vascular permeability index (PVPI) of patients
with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), cardiogenic edema, and pleural effusion with atelectasis on the day of
enrollment and the maximal value during the study period. (A) PVPI was higher in ALI/ARDS patients than in cardiogenic edema and pleural
effusion with atelectasis patients. There was no difference in the index between cardiogenic edema and pleural effusion with atelectasis patients.
(B) Differences were found when the maximal index value was compared between day 0 and day 2. Data presented as median (interquartile
range). *P < 0.01 vs. pleural effusion with atelectasis and cardiogenic edema. PVPI-0, pulmonary vascular permeability index on the day of
enrollment; maxPVPI, maximal value of pulmonary vascular permeability index from days 0 to 2.
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Figure 4 Extravascular lung water index and pulmonary vascular permeability index/intrathoracic blood volume correlation in ALI/
ARDS patients. Correlation between extravascular lung water index (EVLWI) and pulmonary vascular permeability index (PVPI) and that between
EVLWI and intrathoracic blood volume (ITBV) in patients with acute lung injury/acute respiratory distress syndrome. There was a strong
correlation between EVLWI and PVPI (r = 0.729, P < 0.01) (A) and a weak correlation between EVLWI and ITBV (r = 0.236, p < 0.01) (B). EVLWI-0,
extravascular lung water index on the day of enrollment; PVPI-0, pulmonary vascular permeability index on the day of enrollment; ITBV-0,









Figure 5 Extravascular lung water index and pulmonary vascular permeability index/intrathoracic blood volume correlation in non-
ALI/ARDS patients. Correlation between extravascular lung water index (EVLWI) and pulmonary vascular permeability index (PVPI) and that
between EVLWI and intrathoracic blood volume (ITBV) in patients with non-acute lung injury (ALI)/acute respiratory distress syndrome (ARDS).
For this analysis, cardiogenic edema and pleural effusion with atelectasis patients were combined as non-ALI/ARDS. EVLWI had a moderate
correlation with PVPI (r = 0.464, P < 0.01) (A) and with ITBV (r = 0.493, P < 0.01) (B). EVLWI-0, extravascular lung water index on the day of
enrollment; PVPI-0, pulmonary vascular permeability index on the day of enrollment; ITBV-0, intrathoracic blood volume on the day of
enrollment.
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(4.7 ± 1.8 vs. 3.2 ± 1.4 in ALI/ARDS and 2.1 ± 0.5 vs. 2.0 ±
0.8 in cardiogenic edema). Although the previous study
did not show the Acute Physiology and Chronic Health
Evaluation II score and mortality, the difference in disease
severity and EVLWI values for inclusion or definition of
pulmonary edema might have influenced the determined
cutoff value for ALI/ARDS. However, the proposed cut-off
value of PVPI ≥ 3 for the diagnosis of ALI/ARDS was
almost the same as the present study, suggesting that this
multicenter study confirmed the proposed value.
The cutoff value for ALI/ARDS should be determined by
considering the balance between sensitivity and specificity.
Clinical trials focusing on specific therapy for ALI/ARDS
should select cutoff values with higher specificity, whereas
those focusing on the early recognition of this condition
and therapeutic intervention should select cutoff values
with high sensitivity. Because the procedures for measur-
ing EVLW and pulmonary vascular permeability are not
non-invasive, the validity of the definite diagnosis of ALI/
ARDS made on the basis of PVPI values that have high
specificity should be considered.
Limitations
The mechanism underlying respiratory insufficiency -
that is, permeability pulmonary edema, cardiogenic
edema, or pleural effusion with atelectasis, which may
be exclusive or overlapped - was defined by expert con-
sensus, and subjectivity therefore cannot be completely
ruled out. Nonetheless, only those patients who were
considered eligible by all the experts were included in
this study and 35 patients were excluded from the ana-
lysis. There may have been some statistical bias in this
regard and the patient population may not represent the
general population of mechanically ventilated patients
with hypoxemic respiratory failure and radiographic
infiltrates. Fourteen of the 35 excluded patients were
judged to have respiratory failure secondary to sepsis-
induced increased pulmonary vascular permeability but
had to be excluded because they presented EVLWI
< 10 ml/kg. This exclusion may bias the study.
Although the study sample size was not small, the num-
ber of patients with cardiogenic pulmonary edema was
fewer than those with ALI/ARDS. Most patients with car-
diogenic pulmonary edema are managed using non-inva-
sive positive pressure ventilation without tracheal
intubation; hence, these patients could not be included in
this study. There may have been some statistical bias in
this regard.
Pulmonary inflammation (that is, pneumonia) needs to
be considered because it might influence the thermodi-
lution technique findings. Inflamed cells and purulent
matter, including microabscesses, may increase lung
weight despite increased EVLW. Further evaluation may
be required to assess ALI/ARDS secondary to direct
injury from pneumonia.
EVLWI ≥ 10 ml/kg was used for defining pulmonary
edema in this study. Although no definitive quantitative
criteria for pulmonary edema were established, this
value was selected on the basis of the value found in
our recent human autopsy study and those used for
ALI/ARDS (n =207) Cardiogenic edema (n =26) 
All patients except for pleural effusion 
with atelectasis (n =233) 
EVLWI-0 EVLWI-0 EVLWI-0
A B C 
Figure 6 Correlation between extravascular lung water index and PaO2/FiO2 ratio. There was a negative and weak correlation between
extravascular lung water index (EVLWI) and PaO2/FiO2 (P/F) ratio in all patients except for pleural effusion with atelectasis patients (r = -0.213, P
< 0.01) (A). In acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) patients (n = 207), a weak correlation between EVLWI and P/F
ratio was observed (r = -0.215, P < 0.01) (B). No correlation between EVLWI and pulmonary vascular permeability index was observed in
cardiogenic edema patients (n = 26; r = -0.176, P = 0.39) (C). EVLWI-0, extravascular lung water index on the day of enrollment; P/F-0, PaO2/FiO2
ratio on the day of enrollment.
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defining pulmonary edema in previously reported stu-
dies. Lowering the EVLWI value for pulmonary edema
may have led to the inclusion of less severe pulmonary
edema cases and might have influenced the diagnostic
cutoff value and its accuracy. However, most of the
patients who had pleural effusion with atelectasis
showed EVLWI < 10 ml/kg, suggesting that the value
was not too low.
Conclusion
This study showed that EVLW was greater in patients
with ALI/ARDS and cardiogenic edema than patients with
pleural effusion with atelectasis; that pulmonary vascular
permeability was increased in patients with ALI/ARDS
compared with cardiogenic edema and pleural effusion
with atelectasis patients; and that the cutoff value of PVPI
for the quantitative diagnosis of ALI/ARDS was between
2.6 and 2.85, with a specificity of 0.9 to 0.95, and that
PVPI < 1.7 ruled out an ALI/ARDS diagnosis (specificity,
0.95).
Key messages
• EVLW was greater in patients with ALI/ARDS and
cardiogenic edema than patients with pleural effu-
sion with atelectasis.
• Pulmonary vascular permeability was increased in
patients with ALI/ARDS compared with cardiogenic
edema and pleural effusion with atelectasis patients.
• The cutoff value of the PVPI for the quantitative
diagnosis of ALI/ARDS was between 2.6 and 2.85,
with a specificity of 0.9 to 0.95, and PVPI < 1.7










1 - Specificity  
Figure 7 Receiver operating characteristic curves for pulmonary vascular permeability index and intrathoracic blood volume. Receiver
operating characteristic curves for pulmonary vascular permeability index (PVPI) and intrathoracic blood volume (ITBV) on the day of enrollment
for the differential diagnosis of acute lung injury/acute respiratory distress syndrome. The area under the curve for PVPI (0.886; confidence
interval, 0.836 to 0.935) was significantly larger than that for ITBI (0.425; confidence interval, 0.359 to 0.529; P < 0.01). PVPI-0, pulmonary vascular
permeability index on the day of enrollment; ITBV-0, intrathoracic blood volume on the day of enrollment.
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